文献速递角膜与眼表疾病

角膜间充质基质细胞通过PEDF和sFLT-1直接发挥抗血管生成作用

Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

研究评估角膜来源间充质基质细胞(Co-MSC)的血管生成特性:Co-MSC分泌组显著抑制人脐静脉内皮细胞(HUVEC)成管和出芽形成,小鼠角膜损伤后应用Co-MSC可预防角膜新生血管形成;去除PEDF或sFLT-1后抗血管生成作用显著减弱,SERPINF1-/-小鼠来源Co-MSC抗血管生成作用较野生型显著降低。

要点

  • Co-MSC分泌组显著抑制HUVEC成管和出芽形成。
  • 小鼠角膜损伤后应用Co-MSC可预防角膜新生血管形成。
  • 去除PEDF或sFLT-1后Co-MSC抗血管生成作用显著减弱。

核心结论

  • Co-MSC具有直接抗血管生成特性,sFLT-1和PEDF起重要作用,可能用于预防病理性角膜新生血管。

研究设计与样本

  • 从人尸体角膜及野生型(C57BL/6J)和SERPINF1-/-小鼠角膜提取Co-MSC,在无血清培养基中收集分泌组。
  • 采用HUVEC成管实验和纤维蛋白凝胶微珠实验(FIBA)出芽实验评估Co-MSC分泌组的血管生成特性。
  • 用完全角膜上皮刮除诱导野生型小鼠角膜新生血管,将包埋于纤维蛋白凝胶的Co-MSC应用于刮除后角膜以评估体内血管生成效应。
  • 采用免疫沉淀法从Co-MSC分泌组中去除sFLT-1和PEDF(SERPINF1基因)。

主要发现

  • Co-MSC分泌组显著抑制HUVEC成管和出芽形成。
  • 不同供体来源Co-MSC均一致含有高水平抗血管生成因子sFLT-1和PEDF,以及低水平血管生成因子VEGF-A。
  • 体内实验中,小鼠角膜损伤后应用Co-MSC可预防角膜新生血管形成。
  • 从分泌组中去除PEDF或sFLT-1后,Co-MSC抗血管生成作用显著减弱。
  • SERPINF1-/-小鼠来源Co-MSC的抗血管生成作用较SERPINF1+/+(野生型)Co-MSC显著降低。

临床怎么用

  • 原文结论认为Co-MSC具有直接抗血管生成特性,sFLT-1和PEDF起重要作用,并可能用于预防病理性角膜新生血管。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the angiogenic properties of corneal derived mesenchymal stromal cells (Co-MSC). METHODS: Co-MSCs were extracted from human cadaver, and wild-type (C57BL/6J) and SERPINF1-/- mice corneas. The MSC secretome was collected in a serum-free medium. Human umbilical vein endothelial cell (HUVEC) tube formation and fibrin gel bead assay (FIBA) sprout formation were used to assess the angiogenic properties of Co-MSC secretome. Complete corneal epithelial debridement was used to induce corneal neovascularization in wild-type mice. Co-MSCs embedded in fibrin gel was applied over the debrided cornea to evaluate the angiogenic effects of Co-MSCs in vivo. Immunoprecipitation was used to remove soluble fms-like tyrosine kinase-1 (sFLT-1) and pigment epithelium-derived factor (PEDF, SERPINF1 gene) from the Co-MSC secretome. RESULTS: Co-MSC secretome significantly inhibited HUVECs tube and sprout formation. Co-MSCs from different donors consistently contained high levels of antiangiogenic factors including sFLT-1 and PEDF; and low levels of the angiogenic factor VEGF-A. In vivo, application of Co-MSCs to mouse corneas after injury prevented the development of corneal neovascularization. Removing PEDF or sFLT-1 from the secretome significantly diminished the antiangiogenic effects of Co-MSCs. Co-MSCs isolated from SERPINF1-/- mice had significantly reduced antiangiogenic effects compared to SERPINF1+/+ (wild-type) Co-MSCs. CONCLUSIONS: These results illustrate the direct antiangiogenic properties of Co-MSCs, the importance of sFLT-1 and PEDF, and their potential clinical application for preventing pathologic corneal neovascularization.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Eslani M, Putra I, Shen X, et al. Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1. Invest Ophthalmol Vis Sci. 2017. PMID: 29075761. doi:10.1167/iovs.17-22680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。